Research ArticleArticle
Anti-interleukin 6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single-center Experience
Stylianos T. Panopoulos, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Aikaterini Arida and Petros P. Sfikakis
The Journal of Rheumatology August 2021, jrheum.210273; DOI: https://doi.org/10.3899/jrheum.210273
Stylianos T. Panopoulos
S.T. Panopoulos, MD, PhD, M.G. Tektonidou, MD, PhD, Professor, V.K. Bournia, MD, PhD, A. Arida, MD, PhD, P.P. Sfikakis, MD, PhD, Professor, Department of First Propaedeutic and Internal Medicine, Joint Rheumatology Program, Medical School of Athens, General Hospital of Athens "LAIKO", Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.T. Panopoulos, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Medical School, General Hospital of Athens, "LAIKO"; 17 Agiou Thoma str., 115 27 Athens, Greece. Email: sty.panopoulos@gmail.com. Accepted for publication August 4, 2021.
Maria G. Tektonidou
S.T. Panopoulos, MD, PhD, M.G. Tektonidou, MD, PhD, Professor, V.K. Bournia, MD, PhD, A. Arida, MD, PhD, P.P. Sfikakis, MD, PhD, Professor, Department of First Propaedeutic and Internal Medicine, Joint Rheumatology Program, Medical School of Athens, General Hospital of Athens "LAIKO", Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.T. Panopoulos, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Medical School, General Hospital of Athens, "LAIKO"; 17 Agiou Thoma str., 115 27 Athens, Greece. Email: sty.panopoulos@gmail.com. Accepted for publication August 4, 2021.
Vasiliki-Kalliopi Bournia
S.T. Panopoulos, MD, PhD, M.G. Tektonidou, MD, PhD, Professor, V.K. Bournia, MD, PhD, A. Arida, MD, PhD, P.P. Sfikakis, MD, PhD, Professor, Department of First Propaedeutic and Internal Medicine, Joint Rheumatology Program, Medical School of Athens, General Hospital of Athens "LAIKO", Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.T. Panopoulos, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Medical School, General Hospital of Athens, "LAIKO"; 17 Agiou Thoma str., 115 27 Athens, Greece. Email: sty.panopoulos@gmail.com. Accepted for publication August 4, 2021.
Aikaterini Arida
S.T. Panopoulos, MD, PhD, M.G. Tektonidou, MD, PhD, Professor, V.K. Bournia, MD, PhD, A. Arida, MD, PhD, P.P. Sfikakis, MD, PhD, Professor, Department of First Propaedeutic and Internal Medicine, Joint Rheumatology Program, Medical School of Athens, General Hospital of Athens "LAIKO", Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.T. Panopoulos, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Medical School, General Hospital of Athens, "LAIKO"; 17 Agiou Thoma str., 115 27 Athens, Greece. Email: sty.panopoulos@gmail.com. Accepted for publication August 4, 2021.
Petros P. Sfikakis
S.T. Panopoulos, MD, PhD, M.G. Tektonidou, MD, PhD, Professor, V.K. Bournia, MD, PhD, A. Arida, MD, PhD, P.P. Sfikakis, MD, PhD, Professor, Department of First Propaedeutic and Internal Medicine, Joint Rheumatology Program, Medical School of Athens, General Hospital of Athens "LAIKO", Athens, Greece. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. S.T. Panopoulos, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Medical School, General Hospital of Athens, "LAIKO"; 17 Agiou Thoma str., 115 27 Athens, Greece. Email: sty.panopoulos@gmail.com. Accepted for publication August 4, 2021.
Article Figures & Data
Additional Files
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Anti-interleukin 6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single-center Experience
Stylianos T. Panopoulos, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Aikaterini Arida, Petros P. Sfikakis
The Journal of Rheumatology Aug 2021, jrheum.210273; DOI: 10.3899/jrheum.210273
Anti-interleukin 6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single-center Experience
Stylianos T. Panopoulos, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Aikaterini Arida, Petros P. Sfikakis
The Journal of Rheumatology Aug 2021, jrheum.210273; DOI: 10.3899/jrheum.210273